Technetium 99m tetrofosmin - GE Healthcare
Alternative Names: 99mTc-tetrofosmin; Myoview; MYOVIEW 30mL; MYOVIEW24; PPN-1011; Tc-99m Tetrofosmin; Tc-99m tetrofosmin SPECT; Tc-99m-PPN1011; Technetium (99MTC) Tetrofosmin; Technetium-Tm99m-tetrofosminLatest Information Update: 30 Sep 2019
At a glance
- Originator Amersham
- Developer Amersham; GE Healthcare
- Class Heavy metals; Imaging agents; Phosphorus compounds; Radiopharmaceutical diagnostics; Technetium compounds
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Coronary disorders; Ischaemia
- Discontinued Brain cancer
Most Recent Events
- 30 Sep 2019 Discontinued - Phase-II for Brain cancer (Diagnosis, In the elderly, In adults) in Germany (IV)
- 07 Jun 2016 Chemical information added
- 26 Apr 2016 Phase II clinical trials in Brain cancer (Diagnosis, In adults, In the elderly) in Germany (IV) (EudraCT2015-005573-21)